| Literature DB >> 31478364 |
Orhan Gokalp1, Levent Yilik1, Yuksel Besir1, Hasan Iner2, Nihan KarakasYesilkaya2, Erturk Karaagac2, Yasar Gokkurt2, Sahin Iscan2, Ali Gurbuz1.
Abstract
OBJECTIVE: Treatment of acute diseases of the aorta is still associated with high mortality and morbidity. It is believed that interventions for these diseases on overtime hours (night shifts or weekend shifts) may increase mortality. In this study, we investigated the effect of performing acute type A aortic dissection surgery on overtime hours in terms of postoperative outcomes.Entities:
Keywords: Acute Diseases; Aneurysm, Dissection; Aorta; Morbity; Pulmonary Disease, Chronic Obstructive; Reoperation
Mesh:
Year: 2019 PMID: 31478364 PMCID: PMC6894032 DOI: 10.21470/1678-9741-2018-0350
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Preoperative data.
| Standard working hours (group 1) n=61 | Overtime hours (group 2) n=145 | |||||
|---|---|---|---|---|---|---|
| Mean±sd/n-% | Med | Mean±sd/n-% | Med | |||
| Age | 54.7±12.5 | 56.0 | 57.5±11.8 | 58.0 | 0.218m | |
| Gender | Female | 27 44.3% | 64 44.1% | 0.987X2 | ||
| Male | 34 55.7% | 81 55.9% | ||||
| DM | 18 29.5% | 30 20.7% | 0.172X2 | |||
| COPD | 29 47.5% | 34 23.4% | 0.001X2 | |||
| Smoking | 36 59.0% | 78 53.8% | 0.491X2 | |||
| CRF | 2 3.3% | 4 2.8% | 1.000X2 | |||
| HT | 50 82.0% | 101 69.7% | 0.068X2 | |||
| Marfan | 4 6.6% | 14 9.7% | 0.472X2 | |||
| BSA | 1.8±0.1 | 1.8 | 1.8±0.1 | 1.8 | 0.153m | |
| Use of antiaggregants | 12 19.7% | 29 20% | 0.957X2 | |||
| Repeat surgery | 18 29.5% | 24 16.6% | 0.035X2 | |||
| Ascending aorta diameter | 55.6±9.7 | 53.0 | 53.6±10.3 | 52.0 | 0.210m | |
| EuroSCORE | 5.4±1.2 | 5.0 | 5.3±1.5 | 5.0 | 0.548m | |
| Malperfusion | 6 9.8% | 14 9.7% | 0.968X2 | |||
| Loss of consciousness | 6 9.8% | 17 11.7% | 0.694X2 | |||
| Shock | 4 6.6% | 11 7.6% | 0.795X2 | |||
| CPR | 1 1.6% | 3 2.1% | 1.000X2 | |||
| Tamponade or effusion | 9 14.8% | 22 15.2% | 0.939X2 | |||
| Hemoglobin (g/dL) | 11.9±1.7 | 11.8 | 11.5±1.7 | 11.5 | 0.266m | |
| WBC >11,000 (K/uL) | 29 47.5% | 70 48.3% | 0.923X2 | |||
| EF <50 | 17 27.9% | 42 29.0% | 0.874X2 | |||
DM=diabetes mellitus, COPD=chronic obstructive pulmonary disease, CRF=chronic renal failure, HT=hypertension, BSA=body surface area, CPR=cardiopulmonary resuscitation, WBC=white blood cells, EF=ejection fraction, tt test. m: Mann-Whitney u test. X²: Chi-square test (Fisher’s test).
Perioperative data.
| Standard working hours (group 1) n=61 | Overtime hours (group 2) n=145 | ||||
|---|---|---|---|---|---|
| Mean±sd/n-% | Med | Mean±sd/n-% | Med | ||
| Cross-clamp time (min) | 121.9±36.1 | 116.0 | 123.2±37.7 | 120.0 | 0.835m |
| CPB time (min) | 181.0±59.7 | 181.0 | 184.7±55.4 | 176.0 | 0.614m |
| Operating time (min) | 340.0±93.1 | 322.0 | 342.9±81.1 | 330.0 | 0.840m |
| Root intervention | 23 37.7% | 38 26.2% | 0.099X2 | ||
| Hemiarch intervention | 26 42.6% | 48 33.1% | 0.194X2 | ||
| Total arch intervention | 11 18.0% | 32 22.1% | 0.515X2 | ||
| Only ascending aortic intervention | 24 39.3% | 65 44.8% | 0.468X2 | ||
| Weaning time (H) | 25.8±19.3 | 22.0 | 30.9±25.2 | 23.5 | 0.201m |
| ICU time (days) | 5.6±4.7 | 4.0 | 6.5±13.9 | 4.0 | 0.293m |
| Hospital discharge time (days) | 11.9±7.0 | 9.0 | 13.1±13.8 | 10.0 | 0.527m |
| Postoperative drainage (ml) | 874±413 | 850 | 903±525 | 800 | 0.827m |
| Blood product (IU) | 3.5±2.5 | 3.0 | 4.0±3.2 | 3.0 | 0.331m |
| POAKI | 9 14.8% | 25 17.2% | 0.661X2 | ||
| Reoperation for bleeding | 20 32.8% | 47 32.4% | 0.958X2 | ||
| Prolonged intubation | 27 44.3% | 75 51.7% | 0.328X2 | ||
| Neurological complication | 8 13.1% | 18 12.4% | 0.890X2 | ||
| Mortality | 6 9.8% | 20 13.8% | 0.485X2 | ||
CPB=cardiopulmonary bypass; ICU=intensive care unit, POAKI=postoperative acute kidney injury. m: Mann-Whitney U test; X2 Chi-square test (Fisher’s test).
Predictors of mortality.
| Univariate analysys | Multivariate analysys | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Cardiopulmonary bypass time | 1.02 | 1.01-1.02 | ||||
| Cross-clamp time | 1.03 | 1.02-1.05 | 1.03 | 1.01-1.05 | ||
| Operating time | 1.01 | 1.00-1.01 | ||||
| Drainage | 1.00 | 1.00-1.00 | 1.00 | 1.00-1.00 | ||
| Intensive care unit time | 1.01 | 0.99-1.04 | ||||
| Blood products | 1.35 | 1.17-1.54 | ||||
| Malperfusion | 3.55 | 1.22-10.29 | ||||
| Loss of consciousness | 39.54 | 13.25-117.9 | 26.8 | 6.06-118.61 | ||
| Reoperation for bleeding | 4.91 | 2.05-11.7 | ||||
| Acute renal failure requiring dialysis | 11.55 | 4.64-28.7 | ||||
| Prolonged intubation | 6.87 | 2.27-20.7 | ||||
| Neurological complication | 20.95 | 7.79-56.3 | 11.9 | 2.76-51.37 | ||
Neurological complication predictors.
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Smoking | 3.05 | 1.17-7.94 | 6.208 | 1.747-22.06 | 0.005 | |
| Cardiopulmonary bypass time | 1.01 | 1.00-1.01 | 1.01 | 1.01-1.02 | 0.030 | |
| Cross-clamp time | 1.02 | 1.01-1.03 | ||||
| Operating time | 1.00 | 1.00-1.01 | ||||
| Drainage | 1.00 | 1.00-1.00 | ||||
| Intensive care unit time | 1.02 | 0.99-1.0 5 | ||||
| Blood products | 1.23 | 1.09-1.38 | ||||
| Hospital discharge time | 1.01 | 0.98-1.03 | ||||
| WBC >11,000 (K/Ul) | 2.75 | 1.13-6.65 | 3.77 | 1.05-13.50 | 0.041 | |
| Loss of consciousness | 8.02 | 3.04-21.2 | ||||
| Reoperation for bleeding | 4.91 | 2.05-11.73 | ||||
| Acute renal failure requiring dialysis | 14.4 | 5.69-36.42 | 16.13 | 5.17-50.33 | 0.000 | |
| Prolonged intubation | 5.13 | 1.85-14.21 | ||||
| Abbreviations, acronyms & symbols | |
|---|---|
| ATAAD | = Acute type A aortic dissection |
| CC | = Cross-clamp |
| COPD | = Chronic obstructive pulmonary disease |
| CPB | = Cardiopulmonary bypass |
| EJCTS | = European Journal of Cardiothoracic Surgery |
| EuroSCORE | = European System for Cardiac Operative Risk Evaluation |
| ICVTS | = Interactive Cardiovascular and Thoracic Surgery |
| MACCEs | = Major adverse cardiac and cerebrovascular events |
| Author's roles & responsibilities | |
|---|---|
| OG | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| LY | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| YB | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| HI | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| NKY | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| EK | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| YG | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| SI | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| AG | Acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |